Perkins Capital Management’s EnteroMedics Inc. ETRM Stock Holding History

Perkins Capital Management’s Portfolio ETRM Stock Details ETRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-5,192	Closed	-$105K	–	128
2016 Q2	$105K	Sell	5,192 -306	-6%	-$14K	0.12%	101
2016 Q1	$372K	Buy	5,498 +228	+4%	+$18.4K	0.47%	66
2015 Q4	$720K	Buy	5,270 +1,710	+48%	+$355K	0.77%	47
2015 Q3	$972K	Buy	+3,560	New	+$1.14M	1.08%	29

Other funds holding ETRM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Perkins Capital Management's ETRM Position: Q3 2016 in Review

Perkins Capital Management sold out of EnteroMedics Inc. (ETRM) in Q3 2016, closing a stake of 5,192 shares — an estimated $105K sold.

Perkins Capital Management first reported a position in ETRM in Q3 2015 and held it in 4 quarters. The position peaked at $972K in Q3 2015. 20 funds tracked by Wall St. Rank hold ETRM as of Q3 2016.

Perkins Capital Management reported no remaining EnteroMedics Inc. position as of Q3 2016 after selling out during the quarter.
Perkins Capital Management sold 5,192 EnteroMedics Inc. shares in Q3 2016, an estimated $105K.
Perkins Capital Management first reported a position in EnteroMedics Inc. in Q3 2015 and held it in 4 quarters.
Perkins Capital Management's EnteroMedics Inc. position peaked at $972K in Q3 2015.
20 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q3 2016.

Based on Perkins Capital Management's 13F filing for Q3 2016, filed 4 Nov 2016.